New Commentary says scientists from developing countries are vitally important in the fight against HIV and they must be given the proper resources to conduct their work <em> - News Release </em>
Imperial College London News Release
For Immediate Release
Monday 22 October 2007
Scientists from developing countries are vitally important in the fight against HIV and they must be given the proper resources to conduct their work, according to a new Commentary published today in the journal Nature Immunology.
Researchers from Imperial College London, who are evaluating multiple candidate vaccines designed to prevent HIV, argue that Western governments and funding agencies must commit to sharing technology and expertise with those in the developing world on a long-term basis.
The researchers have been working with local scientists in Uganda and other sites in the developing world to enable large-scale international trials of potential vaccines against HIV. They argue their work shows that it is both feasible and desirable to carry out high-quality trials in developing countries, but that more state-of-the-art laboratories are needed in the developing world to support such trials and enable the roll-out of antiretroviral drugs.
The authors write that people in countries like Uganda wish to take ownership of, or at the very least be equal partners in, efforts to develop treatments for HIV to benefit their population.
"Old fashioned 'parachute science' – where scientists from the developed world flew in, bled a few patients, and immediately returned to their country of origin with their samples, are no longer required or acceptable. In-house development and research is an effective and efficient way forward," said Professor Frances Gotch, one of the Commentary's authors from the Division of Investigative Science at Imperial College.
Uganda is a relative success story in relation to other parts of sub-Saharan Africa in terms of how it has dealt with the spread of HIV, thanks to a National AIDS Control programme, which was established early in the epidemic. Nonetheless, one million people in the country are living with HIV and contributions from the West have been and continue to be crucial in Uganda and elsewhere, say the authors.
Collaborations across sub-Saharan Africa have so far enabled the creation of network of state-of-the-art laboratories, staffed by local scientists and technologists. Cooperation between the Ugandan government and international bodies has enabled the development of research which has led to improved HIV screening and counselling; free mosquito nets and water purification to prevent opportunistic infections; and free testing and treatment for basic infections of danger to those living with AIDS.
"Western governments and funding agencies need to continue to build capacity and train future generations of scientists and doctors on-site in new technologies," added Professor Gotch. "Countries need resources to maintain and sustain not only the facilities and equipment, but also staff in these countries who are trained and motivated. It is most important to give countries the capacity to train the trainers in their country so that knowledge can be shared and developed there."
The Commentary is part of the Council of Science Editors' global theme issue on poverty and human development, launched today by the National Institutes of Health to coincide with the publication of related research by more than 230 journals worldwide.
-ends-
For further information please contact:
Laura Gallagher
Senior Press Officer
Imperial College London
e-mail: l.gallagher@imperial.ac.uk
Telephone: +44 (0)207 594 6702 or ext. 46702
Out of hours duty Press Officer: +44 (0)7803 886 248
Notes to editors:
1. "Science, medicine and research in the developing world: a perspective" Nature Immunology, 22 October 2007 (Advanced Online Publication – can be viewed at www.nature.com/ni/journal/vaop/ncurrent/full/ni1531.html)
Frances Gotch and Jill Gilmour - Division of Investigative Science, Imperial College London
2. About Imperial College London
Rated as the world's ninth best university in the 2006 Times Higher Education Supplement University Rankings, Imperial College London is a science-based institution with a reputation for excellence in teaching and research that attracts 11,500 students and 6,000 staff of the highest international quality.
Innovative research at the College explores the interface between science, medicine, engineering and management and delivers practical solutions that improve quality of life and the environment - underpinned by a dynamic enterprise culture.
With 62 Fellows of the Royal Society among our current academic staff and distinguished past members of the College including 14 Nobel Laureates and two Fields Medallists, Imperial's contribution to society has been immense. Inventions and innovations include the discovery of penicillin, the development of holography and the foundations of fibre optics. This commitment to the application of our research for the benefit of all continues today with current focuses including interdisciplinary collaborations to tackle climate change and mathematical modelling to predict and control the spread of infectious diseases.
The College's 100 years of living science will be celebrated throughout 2007 with a range of events to mark the Centenary of the signing of Imperial's founding charter on 8 July 1907. Website: www.imperial.ac.uk
Article text (excluding photos or graphics) available under an Attribution-NonCommercial-ShareAlike Creative Commons license.
Photos and graphics subject to third party copyright used with permission or © Imperial College London.
